|
1
|
Vokes EE, Weichselbaum RR, Lippman SM and
Hong WK: Head and neck cancer. N Engl J Med. 328:184–194. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Prince ME, Sivanandan R, Kaczorowski A, et
al: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang P, Zuo H, Ozaki T, Nakagomi N and
Kakudo K: Cancer stem cell hypothesis in thyroid cancer. Pathol
Int. 56:485–489. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Franzmann EJ, Reategui EP, Pedroso F, et
al: Soluble CD44 is a potential marker for the early detection of
head and neck cancer. Cancer Epidemiol Biomarkers Prev.
16:1348–1355. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Saito H, Tsujitani S, Katano K, Ikeguchi
M, Maeta M and Kaibara N: Serum concentration of CD44 variant 6 and
its relation to prognosis in patients with gastric carcinoma.
Cancer. 83:1094–1101. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ponta H, Wainwright D and Herrlich P: The
CD44 protein family. Int J Biochem Cell Biol. 30:299–305. 1998.
View Article : Google Scholar
|
|
7
|
Screaton GR, Bell MV, Bell JI and Jackson
DG: The identification of a new alternative exon with highly
restricted tissue expression in transcripts encoding the mouse
Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons
between mouse, human, and rat. J Biol Chem. 268:12235–12238.
1993.
|
|
8
|
Screaton GR, Bell MV, Jackson DG, Cornelis
FB, Gerth U and Bell JI: Genomic structure of DNA encoding the
lymphocyte homing receptor CD44 reveals at least 12 alternatively
spliced exons. Proc Natl Acad Sci USA. 89:12160–12164. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Picker LJ, Nakache M and Butcher EC:
Monoclonal antibodies to human lymphocyte homing receptors define a
novel class of adhesion molecules on diverse cell types. J Cell
Biol. 109:927–937. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stamenkovic I, Amiot M, Pesando JM and
Seed B: A lymphocyte molecule implicated in lymph node homing is a
member of the cartilage link protein family. Cell. 56:1057–1062.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gunthert U, Hofmann M, Rudy W, et al: A
new variant of glycoprotein CD44 confers metastatic potential to
rat carcinoma cells. Cell. 65:13–24. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hofmann M, Rudy W, Zoller M, et al: CD44
splice variants confer metastatic behavior in rats: homologous
sequences are expressed in human tumor cell lines. Cancer Res.
51:5292–5297. 1991.PubMed/NCBI
|
|
13
|
Thenappan A, Li Y, Shetty K, Johnson L,
Reddy EP and Mishra L: New therapeutics targeting colon cancer stem
cells. Curr Colorectal Cancer Rep. 5:2092009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zlobec I, Gunthert U, Tornillo L, et al:
Systematic assessment of the prognostic impact of membranous CD44v6
protein expression in colorectal cancer. Histopathology.
55:564–575. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park SY, Lee HE, Li H, Shipitsin M, Gelman
R and Polyak K: Heterogeneity for stem cell-related markers
according to tumor subtype and histologic stage in breast cancer.
Clin Cancer Res. 16:876–887. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Okayama H, Kumamoto K, Saitou K, et al:
CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for
prediction of lymph node metastasis in primary gastric cancer.
Oncol Rep. 22:745–755. 2009.PubMed/NCBI
|
|
17
|
Dar A, Goichberg P, Shinder V, et al:
Chemokine receptor CXCR4-dependent internalization and resecretion
of functional chemokine SDF-1 by bone marrow endothelial and
stromal cells. Nat Immunol. 6:1038–1046. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Faber A, Roderburg C, Wein F, et al: The
many facets of SDF-1alpha, CXCR4 agonists and antagonists on
hematopoietic progenitor cells. J Biomed Biotechnol.
2007:260652007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Imai K, Kobayashi M, Wang J, et al:
Selective secretion of chemoattractants for haemopoietic progenitor
cells by bone marrow endothelial cells: a possible role in homing
of haemopoietic progenitor cells to bone marrow. Br J Haematol.
106:905–911. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
De La Luz Sierra M, Yang F, Narazaki M, et
al: Differential processing of stromal-derived factor-1alpha and
stromal-derived factor-1beta explains functional diversity. Blood.
103:2452–2459. 2004.PubMed/NCBI
|
|
21
|
Shirozu M, Nakano T, Inazawa J, et al:
Structure and chromosomal localization of the human stromal
cell-derived factor 1 (SDF1) gene. Genomics. 28:495–500. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim CH and Broxmeyer HE: In vitro behavior
of hematopoietic progenitor cells under the influence of
chemoattractants: stromal cell-derived factor-1, steel factor, and
the bone marrow environment. Blood. 91:100–110. 1998.PubMed/NCBI
|
|
23
|
Mohle R, Bautz F, Rafii S, Moore MA,
Brugger W and Kanz L: The chemokine receptor CXCR-4 is expressed on
CD34+ hematopoietic progenitors and leukemic cells and
mediates transendothelial migration induced by stromal cell-derived
factor-1. Blood. 91:4523–4530. 1998.PubMed/NCBI
|
|
24
|
Petit I, Goichberg P, Spiegel A, et al:
Atypical PKC-zeta regulates SDF-1-mediated migration and
development of human CD34+ progenitor cells. J Clin
Invest. 115:168–176. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chute JP: Stem cell homing. Curr Opin
Hematol. 13:399–406. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fruehauf S, Srbic K, Seggewiss R, Topaly J
and Ho AD: Functional characterization of podia formation in normal
and malignant hematopoietic cells. J Leukoc Biol. 71:425–432.
2002.PubMed/NCBI
|
|
27
|
Lataillade JJ, Clay D, Dupuy C, et al:
Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in
synergy with cytokines: possible role in progenitor survival.
Blood. 95:756–768. 2000.
|
|
28
|
Broxmeyer HE, Kohli L, Kim CH, et al:
Stromal cell-derived factor-1/CXCL12 directly enhances
survival/antiapoptosis of myeloid progenitor cells through CXCR4
and G(alpha)i proteins and enhances engraftment of competitive,
repopulating stem cells. J Leukoc Biol. 73:630–638. 2003.
View Article : Google Scholar
|
|
29
|
Kijowski J, Baj-Krzyworzeka M, Majka M, et
al: The SDF-1-CXCR4 axis stimulates VEGF secretion and activates
integrins but does not affect proliferation and survival in
lymphohematopoietic cells. Stem Cells. 19:453–466. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hattori K, Heissig B, Tashiro K, et al:
Plasma elevation of stromal cell-derived factor-1 induces
mobilization of mature and immature hematopoietic progenitor and
stem cells. Blood. 97:3354–3360. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Goichberg P, Kalinkovich A, Borodovsky N,
et al: cAMP-induced PKCzeta activation increases functional CXCR4
expression on human CD34+ hematopoietic progenitors.
Blood. 107:870–879. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tudan C, Willick GE, Chahal S, et al:
C-terminal cyclization of an SDF-1 small peptide analogue
dramatically increases receptor affinity and activation of the
CXCR4 receptor. J Med Chem. 45:2024–2031. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Grenman R, Burk D, Virolainen E, Wagner
JG, Lichter AS and Carey TE: Radiosensitivity of head and neck
cancer cells in vitro. A 96-well plate clonogenic cell assay for
squamous cell carcinoma. Arch Otolaryngol Head Neck Surg.
114:427–431. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Domanska UM, Kruizinga RC, Nagengast WB,
et al: A review on CXCR4/CXCL12 axis in oncology: No place to hide.
Eur J Cancer. June 8–2012.(Epub ahead of print).
|
|
35
|
Pries R, Wittkopf N, Hasselbacher K and
Wollenberg B: Constitutive expression of the potential stem cell
marker CD44 in permanent HNSCC cell lines. Hno. 56:461–466.
2008.(In German).
|
|
36
|
Wollenberg B: Implication of stem cells in
the biology and therapy of head and neck cancer.
Laryngorhinootologie. 90(Suppl 1): S110–S119. 2011.(In German).
|
|
37
|
Zhang Z, Filho MS and Nor JE: The biology
of head and neck cancer stem cells. Oral Oncol. 48:1–9. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
La Porta CA: Thoughts about cancer stem
cells in solid tumors. World J Stem Cells. 4:17–20. 2012.PubMed/NCBI
|
|
39
|
Jaggupilli A and Elkord E: Significance of
CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity.
Clin Dev Immunol. 2012:7080362012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Clay MR, Tabor M, Owen JH, et al:
Single-marker identification of head and neck squamous cell
carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck.
32:1195–1201. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li KC, Huang YH, Ho CY, et al: The role of
IL-8 in the SDF-1alpha/CXCR4-induced angiogenesis of laryngeal and
hypopharyngeal squamous cell carcinoma. Oral Oncol. 48:507–515.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Teicher BA and Fricker SP: CXCL12
(SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res. 16:2927–2931.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Stenvik J, Sletta H, Grimstad O, et al:
Alginates induce differentiation and expression of CXCR7 and
CXCL12/SDF-1 in human keratinocytes-The role of calcium. J Biomed
Mater Res A. 100:2803–2812. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gentilini A, Rombouts K, Galastri S, et
al: Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the
interaction between hepatic stellate cells and cholangiocarcinoma.
J Hepatol. June 19–2012.(Epub ahead of print).
|
|
45
|
Chen J and Gallo KA: MLK3 regulates
paxillin phosphorylation in chemokine-mediated breast cancer cell
migration and invasion to drive metastasis. Cancer Res.
72:4130–4140. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jin F, Brockmeier U, Otterbach F and
Metzen E: New insight into the SDF-1/CXCR4 axis in a breast
carcinoma model: Hypoxia-induced endothelial SDF-1 and tumor cell
CXCR4 are required for tumor cell intravasation. Mol Cancer Res.
10:1021–1031. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Flores-Figueroa E, Varma S, Montgomery K,
Greenberg PL and Gratzinger D: Distinctive contact between
CD34+ hematopoietic progenitors and CXCL12+
CD271+ mesenchymal stromal cells in benign and
myelodysplastic bone marrow. Lab Invest. 92:1330–1341. 2012.
|
|
48
|
Purizaca J, Meza I and Pelayo R: Early
lymphoid development and microenvironmental cues in B-cell acute
lymphoblastic leukemia. Arch Med Res. 43:89–101. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Juarez J, Dela Pena A, Baraz R, et al:
CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia
cells into the peripheral blood and inhibit engraftment. Leukemia.
21:1249–1257. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nervi B, Ramirez P, Rettig MP, et al:
Chemosensitization of acute myeloid leukemia (AML) following
mobilization by the CXCR4 antagonist AMD3100. Blood. 113:6206–6214.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Faber A, Barth C, Hormann K, et al: CD44
as a stem cell marker in head and neck squamous cell carcinoma.
Oncol Rep. 26:321–326. 2011.PubMed/NCBI
|
|
52
|
Geutskens SB, Andrews WD, van Stalborch
AM, et al: Control of human hematopoietic stem/progenitor cell
migration by the extracellular matrix protein Slit3. Lab Invest.
92:1129–1139. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ghosh MC, Makena PS, Gorantla V, Sinclair
SE and Waters CM: CXCR4 regulates migration of lung alveolar
epithelial cells through activation of Rac1 and matrix
metalloproteinase-2. Am J Physiol Lung Cell Mol Physiol.
302:L846–L856. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Faber A, Sauter A, Hoedt S, et al:
Alteration of MMP-2 and -14 expression by imatinib in HPV-positive
and -negative squamous cell carcinoma. Oncol Rep. 28:172–178.
2012.PubMed/NCBI
|
